Cross‐presentation of a CMV pp65 epitope by human dendritic cells using bee venom PLA2 as a membrane‐binding vector

Authors:
  • CAChristine Almunia
    Christine Almunia
  • CBClaire Boccaccio
    Claire Boccaccio
  • MGMichael H. Gelb
    Michael H. Gelb
  • AMAndré Ménez
    André Ménez
  • BMBernard Maillère
    Bernard Maillère
  • JAJean-Pierre Abastado
    Jean-Pierre Abastado
  • MSMargarita Salcedo
    Margarita Salcedo
  • DGDaniel Gillet
    Daniel Gillet

Abstract
We have used bee venom phospholipase A2 as a vector to load human dendritic cells ex vivo with a major histocompatibility complex (MHC) class I-restricted epitope fused to its C-terminus. The fusion protein bound to human monocyte-derived dendritic cells and was internalized into early endosomes. In vitro immunization experiments showed that these dendritic cells were able to generate specific CD8 T cell lines against the epitope carried by the fusion protein. Cross-presentation did not require proteasome, transporter associated with antigen processing, or endosome proteases, but required newly synthesized MHC molecules. Comparison of the antigen presentation pathway observed in this study to that followed by other toxins used as vectors is discussed.

This publication has 35 references indexed in Scilit: